Ben York Email & Phone Number

Genetica is home to Flora, Flora is a Neural Dynamic Knowledge System (NDKS). The system is architecturally defined as a number of Artificial Neural Networks (ANN/NN) nested within a predetermined array of Expert Systems (ES) arranged within a hierarchical structure guided by Flora's proprietary Primary Controller. Essentially, imagine walking into a CVS pharmacy or any Cannabis/CBD store in the country and immediately being directed to the tablet that houses Flora, who will then manage the entire end to end process of identification, collaboration and distribution of the medicine and products. This is all happening while Flora powers the entire decision making process for the retailers, thus controlling the ecosystem!Flora's Neural Network exists where ML algorithms are utilized with a specific purpose and in a way that emulates the operational behavior of a human brain. So no need exists for them to deal with the headaches of managing their 8+ other software systems as Flora manages them all for them!Our motivation to build Flora is that we have identified a gap in the market, specifically in the Cannabis retail world (40k+ globally), retailers lose billions annually to operational deficiencies, the “known unknowns”. All while operating a myriad of different softwares to run and manage their operations and more.

Genetica is home to Flora, the first and only AI for cannabis and CBD products. Flora represents a data pool of over 650 million sources utilized in real-time to scientifically select the best product recommendations for individual consumers.A combination of machine-learning science and consumer data, Flora creates a more informed customer and sparks a smarter conversation between your staff and the customer.

San Francisco, California, Us

Venture Capital firm investing across the cannabis ecosystem

Palo Alto, Ca, Us

San Francisco, California, Us

San Francisco, California, Us

- Joined Venture University's investment team as part of cohort 2 SF, which included 22 investors that were sourced from over 4,000 applications and had a 0.5% acceptance rate- Venture University is a multi-stage investment fund, making initial investments of $20K-$1M, and follow-on investments up to $15M. Venture University's large investment team enables it to cover markets broader, deeper, and faster than a traditional fund, and offers portfolio companies access to a powerful network- Built a large network of VC/PE investors, accelerators, and strategics, and with Venture University's network can get access to most VC investors and portfolio companies- Identified and sourced investment opportunities across industries including consumer, enterprise, marketplaces, AI, robotics, and big data by analyzing market landscapes and developing investment theses- Reviewed pitch decks and met with many companies raising capital (seed through growth stage), conducted initial and deeper due diligence, including evaluating companies based on core criteria: target market size, founder and product market fit, business model & financial analysis, competitive landscape, growth plan and exit potential, understanding the cap table, and reviewing the investment terms- Drafted investment evaluations and recommendations, and presented to the investment committee for approval co-investment opportunities alongside other investors including top angels, seed, VC funds- Worked closely with and learned from top performing Managing Directors, including Andrew Zalasin (Former General Partner at RRE Ventures for ~20 years, a $1.5B venture fund), and J. Skyler Fernandes (Powerlist 100 VC, Founder of Simon Venture Group and Cleveland Avenue )- As part of Venture University's alumni network, I continue to support the portfolio companies by making introductions to potential clients, partners, employees, advisors, investors, and acquirers

Santa Monica, Ca, Us

Santa Monica, Ca, Us

Mentor in the Eaze Momentum Accelerator program for underrepresented founders of cannabis companies

Austin, Tx, Us

San Francisco, Ca, Us

San Francisco, Ca, Us

Founded in 2010, The Arcview Group is the first and largest group of investors dedicated to the legal cannabis industry. Since inception, Arcview Group investors have placed $230+ million behind hundreds of companies that have come through the network. Companies such as Eaze, 4Front, MedMen, Tokyo Smoke, Ebbu, Mjardin, SPARC, Mirth, Flowhub, Leaf, Wurk, Meadow, Medicine Man, The Goodship, Steep Hill, Growcentia, and many others.Arcview Market Research publishes the most oft-cited data and analysis on the sector and is regularly quoted in the New York Times, Wall Street Journal, Los Angeles Times, Fortune Magazine and almost every other major media outlet. Arcview is also partner in Canopy, the first and leading seed-stage mentor-driven business accelerator, which has invested in more than 75 companies. Arcview also co-founded Cannasure Insurance Services, the leading provider of business insurance to the cannabis industry. Forbes Magazine named Arcview among the top 5 financial firms in the cannabis sector.

San Francisco, California, Us

- Generate new business opportunities through both outbound calling and emailing doctors and managers at private medical practices- Increase revenue by over $234k from 8 accounts closed- Design and report key performance metrics and deliver insights to improve messaging- Demonstrate Remedly Practice Management software to potential clients, showing them how to increase operational efficiencies across multiple private medical practices- Engage in contract negotiation, maximizing revenue per contract and amending contracts by adding or removing clauses to find agreeable terms

San Francisco, California, Us

Remedly is a cloud-based, data-centric ERP system for physicians and their patients. Our solution provides medical practices an all-in-one integrated EHR / Practice Management / Revenue Monitoring / Analytics system and their patients with an online concierge service. Remedly eliminates the need for multiple software tools, saving staff time, increasing profitability, and enhancing patient experience.

New York, New York, Us

EQUITY DERIVATIVES AND GLOBAL SECURITIZED MARKETS- Analyze and sell listed and over-the-counter equity derivatives, Delta 1, and Risk Premia products.- Sell to institutional clients for the Equity Derivatives group within the Markets division.- Rotate through Global Securitized Markets (GSM) group within Markets division- Analyze and sell agency Mortgage Backed Securities (MBS) as well as other securitized products.- Sell to institutional clients based on investment profile.- Serve as back up to the Equity Derivatives and GSM sales teams.- Provide seamless coverage for institutional clients, allowing the sales team to visit clients.- Create actionable trade ideas in both Equity Derivatives and GSM, providing clients profitable trades.- Produce solutions to client inquiries, including trading various investment products.- Research specific industries, resolving settlements issues between clients and international office.SUMMER INTERN (2014)

Waterville, Maine, Us

Mayflower Hill Capital is a student-run investment fund that manages its members' assets. MHC focuses primarily on long/short equity investing using qualitative and quantitative assessments of the micro and macro environment.

Zurich, Ch

- Worked in the GSM group interacting with traders within subsectors of securitized products.- Assisted in agency MBS.- Completed projects assessing various principles underlying the mortgage market.- Assessed prepayments/ convexity.- Wrote weekly market updates for the head of sales including macro-economic and MBS analysis.- Generated amortization tables, dollar roll calculators, and bond pricing models using Microsoft.